Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers

This Gaucher disease review considered 3 enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health.

Scroll down to access downloads and media.

Downloads

Life Saving Drugs Program – Gaucher disease – Medicines review summary for consumers

Download PDF - 157.39 KB - 3 pages

Download Word - 108.65 KB - 3 pages

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:

27 January 2023

Publication type:

Procedure

Audience:

General public

Language:

English

Part of a collection:

Life Saving Drugs Program resources – Gaucher disease

Tags:

Chronic conditions
Medicines
Life Saving Drugs Program

Sub menu

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers

Downloads

Life Saving Drugs Program – Gaucher disease – Medicines review summary for consumers

Help us improve health.gov.au